160 related articles for article (PubMed ID: 10427623)
1. C1q: a multifunctional ligand for a new immunoadsorption treatment.
Hiepe F; Pfüller B; Wolbart K; Bruns A; Leinenbach HP; Hepper M; Schössler W; Otto V
Ther Apher; 1999 Aug; 3(3):246-51. PubMed ID: 10427623
[TBL] [Abstract][Full Text] [Related]
2. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro.
Pang Y; Yang XW; Song Y; Yu F; Zhao MH
Immunobiology; 2014 Dec; 219(12):980-9. PubMed ID: 25092568
[TBL] [Abstract][Full Text] [Related]
3. Complement component c1q and anti-c1q antibodies in theory and in clinical practice.
Potlukova E; Kralikova P
Scand J Immunol; 2008 May; 67(5):423-30. PubMed ID: 18363591
[TBL] [Abstract][Full Text] [Related]
4. [Apoptosis and C1q: possible explanations for the pathogenesis of systemic lupus erythematosus].
Trendelenburg M; Schifferli JA
Z Rheumatol; 2000 Jun; 59(3):172-5. PubMed ID: 10929445
[TBL] [Abstract][Full Text] [Related]
5. C1q as antigen in humoral autoimmune responses.
Siegert CE; Daha MR
Immunobiology; 1998 Aug; 199(2):295-302. PubMed ID: 9777413
[TBL] [Abstract][Full Text] [Related]
6. C1q and systemic lupus erythematosus.
Walport MJ; Davies KA; Botto M
Immunobiology; 1998 Aug; 199(2):265-85. PubMed ID: 9777411
[TBL] [Abstract][Full Text] [Related]
7. C1q, autoimmunity and apoptosis.
Botto M; Walport MJ
Immunobiology; 2002 Sep; 205(4-5):395-406. PubMed ID: 12396002
[TBL] [Abstract][Full Text] [Related]
8. C1q, antibodies and anti-C1q autoantibodies.
Beurskens FJ; van Schaarenburg RA; Trouw LA
Mol Immunol; 2015 Nov; 68(1):6-13. PubMed ID: 26032012
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
[TBL] [Abstract][Full Text] [Related]
10. Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation.
Dijkstra DJ; van de Bovenkamp FS; Abendstein L; Zuijderduijn R; Pool J; Kramer CSM; Slot LM; Drijfhout JW; de Vor L; Gelderman KA; Rooijakkers SHM; Zaldumbide A; Vidarsson G; Sharp TH; Parren PWHI; Trouw LA
Proc Natl Acad Sci U S A; 2023 Dec; 120(50):e2310666120. PubMed ID: 38048459
[TBL] [Abstract][Full Text] [Related]
11. Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus.
Wisnieski JJ; Jones SM
J Immunol; 1992 Mar; 148(5):1396-403. PubMed ID: 1538123
[TBL] [Abstract][Full Text] [Related]
12. [Structure and function of complement protein C1q and its role in the development of autoimmune diseases].
Smykał-Jankowiak K; Niemir ZI
Postepy Hig Med Dosw (Online); 2009 Apr; 63():134-41. PubMed ID: 19373194
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus.
Shoenfeld Y; Szyper-Kravitz M; Witte T; Doria A; Tsutsumi A; Tatsuya A; Dayer JM; Roux-Lombard P; Fontao L; Kallenberg CG; Bijl M; Matthias T; Fraser A; Zandman-Goddard G; Blank M; Gilburd B; Meroni PL
Ann N Y Acad Sci; 2007 Jun; 1108():227-39. PubMed ID: 17899624
[TBL] [Abstract][Full Text] [Related]
14. [Autoantibodies against the complement component C1q in systemic lupus erythematosus].
Antes U; Heinz HP; Hartung K; Loos M
Klin Wochenschr; 1990 Nov; 68(21):1066-70. PubMed ID: 2084321
[TBL] [Abstract][Full Text] [Related]
15. Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus.
Holers VM
J Clin Invest; 2004 Sep; 114(5):616-9. PubMed ID: 15343378
[TBL] [Abstract][Full Text] [Related]
16. C1q knock-out mice for the study of complement deficiency in autoimmune disease.
Botto M
Exp Clin Immunogenet; 1998; 15(4):231-4. PubMed ID: 10072632
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against C1q in patients with systemic lupus erythematosus.
Trendelenburg M
Springer Semin Immunopathol; 2005 Nov; 27(3):276-85. PubMed ID: 16189648
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA
Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
[TBL] [Abstract][Full Text] [Related]
19. Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways.
Thanei S; Vanhecke D; Trendelenburg M
Clin Immunol; 2015 Oct; 160(2):180-7. PubMed ID: 26148903
[TBL] [Abstract][Full Text] [Related]
20. Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus.
Antes U; Heinz HP; Loos M
Arthritis Rheum; 1988 Apr; 31(4):457-64. PubMed ID: 3258749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]